XML 18 R40.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
The loss from operations before tax (expense) benefit consisted of the following for the years ended December 31, 2019, 2018, and 2017:
 
 
2019
 
2018
 
2017
Domestic
 
$
(231,915
)
 
$
(68,461
)
 
$
(54,588
)
Foreign
 
(8,011
)
 
(59,649
)
 
(23,077
)
Total
 
$
(239,926
)
 
$
(128,110
)
 
$
(77,665
)

Components of Income Tax Provision
The Income Tax Provision consisted of the following for the years ended December 31, 2019, 2018 and 2017:
 
 
2019
 
2018
 
2017
Current:
 
 

 
 

 
 
U.S. Federal
 
$

 
$

 
$

U.S. State and Local
 
(61
)
 
(38
)
 
(6
)
Foreign
 
(2,041
)
 
(669
)
 
(1,131
)
Deferred:
 
 
 
 
 
 
U.S. Federal
 

 

 
(198
)
U.S. State and Local
 
(8,812
)
 

 

Foreign
 
(736
)
 
736

 

Total tax benefit (expense)
 
$
(11,650
)
 
$
29

 
$
(1,335
)

Schedule of reconciliation of the U.S. statutory income tax rate to the Company's effective tax rate
A reconciliation of the U.S. statutory income tax rate to the Company’s effective tax rate is as follows:
 
 
December 31,
 
 
2019
 
2018
 
2017
Federal income tax provision at statutory rate
 
21.00
 %
 
21.00
 %
 
34.00
 %
State income tax provision, net of federal benefit
 
1.08

 
0.05

 
(1.01
)
Permanent differences
 
(6.17
)
 
(6.41
)
 
(8.48
)
Research and development
 
4.38

 
6.49

 
19.53

Change in valuation allowances
 
(35.49
)
 
2.20

 
29.10

Change in deferred tax assets
 
15.89

 
(14.22
)
 
(64.12
)
Foreign tax rate differential
 
(1.88
)
 
(9.10
)
 
(10.33
)
Benefit allocated from other comprehensive income
 

 

 
(0.26
)
Tax rate change
 
(3.67
)
 

 

Other
 

 
0.01

 
(0.15
)
Effective income tax rate
 
(4.86
)%
 
0.02
 %
 
(1.72
)%

Schedule of significant components of the Company's deferred tax assets and liabilities
The significant components of the Company’s deferred tax assets and liabilities at December 31, 2019 and 2018 are as follows:
 
 
2019
 
2018
Deferred tax assets:
 
 

 
 

Accrued expense
 
$
2,588

 
$
714

Amortization
 
78,291

 
5,148

Depreciation
 
991

 
1,601

Federal tax credits
 
99,421

 
89,070

State tax credits
 
6,489

 
5,473

Federal net operating losses
 
91,010

 
62,159

State net operating losses
 
1,360

 
165

Foreign net operating losses
 
1,056

 
736

Capitalized research and development costs
 
1,274

 
2,093

Share based compensation and other
 
16,425

 
21,411

   Other comprehensive loss
 
1,512

 

Total gross deferred tax assets
 
300,417

 
188,570

Less valuation allowance
 
(267,131
)
 
(180,481
)
Total deferred tax assets, net of valuation allowance
 
$
33,286

 
$
8,089

Deferred tax liabilities:
 
 

 
 

Convertible debt
 
$
(33,286
)
 
$
(7,353
)
 Indefinite lived intangible
 
(130,862
)
 
(122,032
)
Total gross deferred tax liabilities
 
(164,148
)
 
(129,385
)
Net deferred tax assets (liabilities)
 
$
(130,862
)
 
$
(121,296
)